FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2994487010> ?p ?o ?g. }

• W2994487010 endingPage "724" @default.
• W2994487010 startingPage "715" @default.
• W2994487010 abstract "To report a planned analysis of the efficacy and toxicity of dose escalation to the intraprostatic dominant nodule identified on multiparametric magnetic resonance imaging using standard and hypofractionated external beam radiation therapy.DELINEATE is a single centre prospective phase 2 multicohort study including standard (cohort A: 74 Gy in 37 fractions) and moderately hypofractionated (cohort B: 60 Gy in 20 fractions) prostate image guided intensity modulated radiation therapy in patients with National Comprehensive Cancer Network intermediate- and high-risk disease. Patients received an integrated boost of 82 Gy (cohort A) and 67 Gy (cohort B) to lesions visible on multiparametric magnetic resonance imaging. Fifty-five patients were treated in cohort A, and 158 patients were treated in cohort B; the first 50 sequentially treated patients in cohort B were included in this planned analysis. The primary endpoint was late Radiation Therapy Oncology Group rectal toxicity at 1 year. Secondary endpoints included acute and late toxicity measured with clinician- and patient-reported outcomes at other time points and biochemical relapse-free survival for cohort A. Median follow-up was 74.5 months for cohort A and 52.0 months for cohort B.In cohorts A and B, 27% and 40% of patients, respectively, were classified as having National Comprehensive Cancer Network high-risk disease. The cumulative 1-year incidence of Radiation Therapy Oncology Group grade 2 or worse rectal and urinary toxicity was 3.6% and 0% in cohort A and 8% and 10% in cohort B, respectively. There was no reported late grade 3 rectal toxicity in either cohort. Within cohort A, 4 of 55 (7%) patients had biochemical relapse.Delivery of a simultaneous integrated boost to intraprostatic dominant nodules is feasible in prostate radiation therapy using standard and moderately hypofractionated regimens, with rectal and genitourinary toxicity comparable to contemporary series without an intraprostatic boost." @default.
• W2994487010 created "2019-12-13" @default.
• W2994487010 creator A5003388016 @default.
• W2994487010 creator A5004002479 @default.
• W2994487010 creator A5011330633 @default.
• W2994487010 creator A5025921361 @default.
• W2994487010 creator A5033672260 @default.
• W2994487010 creator A5035228430 @default.
• W2994487010 creator A5040273298 @default.
• W2994487010 creator A5041059810 @default.
• W2994487010 creator A5047234703 @default.
• W2994487010 creator A5057867093 @default.
• W2994487010 creator A5060445631 @default.
• W2994487010 creator A5061512010 @default.
• W2994487010 creator A5062218386 @default.
• W2994487010 creator A5079070729 @default.
• W2994487010 creator A5088376729 @default.
• W2994487010 date "2020-03-01" @default.
• W2994487010 modified "2023-10-16" @default.
• W2994487010 title "Standard and Hypofractionated Dose Escalation to Intraprostatic Tumor Nodules in Localized Prostate Cancer: Efficacy and Toxicity in the DELINEATE Trial" @default.
• W2994487010 cites W1671682816 @default.
• W2994487010 cites W1789162631 @default.
• W2994487010 cites W1968128042 @default.
• W2994487010 cites W1968626722 @default.
• W2994487010 cites W1977970364 @default.
• W2994487010 cites W1992743783 @default.
• W2994487010 cites W1998201907 @default.
• W2994487010 cites W2001273577 @default.
• W2994487010 cites W2001432092 @default.
• W2994487010 cites W2004080729 @default.
• W2994487010 cites W2012285222 @default.
• W2994487010 cites W2014565774 @default.
• W2994487010 cites W2021458699 @default.
• W2994487010 cites W2033645471 @default.
• W2994487010 cites W2035429331 @default.
• W2994487010 cites W2046267671 @default.
• W2994487010 cites W2059842435 @default.
• W2994487010 cites W2072846282 @default.
• W2994487010 cites W2086900631 @default.
• W2994487010 cites W2093867637 @default.
• W2994487010 cites W2095549404 @default.
• W2994487010 cites W2108882655 @default.
• W2994487010 cites W2115895082 @default.
• W2994487010 cites W2131398800 @default.
• W2994487010 cites W2144574555 @default.
• W2994487010 cites W2152182740 @default.
• W2994487010 cites W2337386322 @default.
• W2994487010 cites W2465092116 @default.
• W2994487010 cites W2466915601 @default.
• W2994487010 cites W2469323349 @default.
• W2994487010 cites W2524920006 @default.
• W2994487010 cites W2590697598 @default.
• W2994487010 cites W2603384438 @default.
• W2994487010 cites W2613076453 @default.
• W2994487010 cites W2783618800 @default.
• W2994487010 cites W2894079334 @default.
• W2994487010 cites W2924320407 @default.
• W2994487010 cites W2952903287 @default.
• W2994487010 cites W2956285030 @default.
• W2994487010 cites W2971549026 @default.
• W2994487010 cites W2973514824 @default.
• W2994487010 cites W2993539218 @default.
• W2994487010 doi "https://doi.org/10.1016/j.ijrobp.2019.11.402" @default.
• W2994487010 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31812718" @default.
• W2994487010 hasPublicationYear "2020" @default.
• W2994487010 type Work @default.
• W2994487010 sameAs 2994487010 @default.
• W2994487010 citedByCount "36" @default.
• W2994487010 countsByYear W29944870102020 @default.
• W2994487010 countsByYear W29944870102021 @default.
• W2994487010 countsByYear W29944870102022 @default.
• W2994487010 countsByYear W29944870102023 @default.
• W2994487010 crossrefType "journal-article" @default.
• W2994487010 hasAuthorship W2994487010A5003388016 @default.
• W2994487010 hasAuthorship W2994487010A5004002479 @default.
• W2994487010 hasAuthorship W2994487010A5011330633 @default.
• W2994487010 hasAuthorship W2994487010A5025921361 @default.
• W2994487010 hasAuthorship W2994487010A5033672260 @default.
• W2994487010 hasAuthorship W2994487010A5035228430 @default.
• W2994487010 hasAuthorship W2994487010A5040273298 @default.
• W2994487010 hasAuthorship W2994487010A5041059810 @default.
• W2994487010 hasAuthorship W2994487010A5047234703 @default.
• W2994487010 hasAuthorship W2994487010A5057867093 @default.
• W2994487010 hasAuthorship W2994487010A5060445631 @default.
• W2994487010 hasAuthorship W2994487010A5061512010 @default.
• W2994487010 hasAuthorship W2994487010A5062218386 @default.
• W2994487010 hasAuthorship W2994487010A5079070729 @default.
• W2994487010 hasAuthorship W2994487010A5088376729 @default.
• W2994487010 hasBestOaLocation W29944870101 @default.
• W2994487010 hasConcept C121608353 @default.
• W2994487010 hasConcept C126322002 @default.
• W2994487010 hasConcept C141071460 @default.
• W2994487010 hasConcept C143998085 @default.
• W2994487010 hasConcept C168563851 @default.
• W2994487010 hasConcept C188816634 @default.
• W2994487010 hasConcept C203092338 @default.
• W2994487010 hasConcept C2780192828 @default.
• W2994487010 hasConcept C29730261 @default.

• next